KathySueAlbainMD

Oncology • Maywood, IL

Professor of Medical Oncology, Loyola University-Stritch School of Medicine

Join to view full profile

Are you Dr. Albain?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 93 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
2160 S First Ave
101-1740
Maywood, IL 60153
Phone+1 708-216-9000

Fax+1 708-216-9033
Is this information wrong?

Summary

Dr. Kathy Albain, MD is an oncologist in Maywood, Illinois. She is currently licensed to practice medicine in Illinois. She is affiliated with Loyola University Medical Center and Gottlieb Memorial Hospital.

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 1981 - 1984
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1979 - 1981
University of Michigan Medical SchoolClass of 1978

Certifications & Licensure

IL State Medical License 1979 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

West Suburban Living Magazine Castle Connolly, 2014
America's Top Doctors Castle Connolly, 2002-2014
Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Women's Health Castle Connolly, 2008
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Top MD Consumers Checkbook
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer Start of enrollment: 1994 Mar 01
Completed
Phase 3
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer Start of enrollment: 2000 Dec 04
Completed
Phase 3
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Start of enrollment: 2003 Oct 01
Completed
Phase 3
S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer Start of enrollment: 2004 Jun 01
Completed
Phase 2
S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer Start of enrollment: 2005 Aug 01
Completed
Phase 2
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone Start of enrollment: 2006 May 01
Withdrawn
Phase 3
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Start of enrollment: 2005 Oct 01
Completed
Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer Start of enrollment: 2008 Feb 14
Completed
Phase 4
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil Start of enrollment: 2006 Jul 01
Completed
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer Start of enrollment: 1989 May 01
Completed
Phase 3
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Recruiting
Phase 2
Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer Start of enrollment: 2010 Mar 01
Withdrawn
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Completed
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
Completed
Phase 3
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Start of enrollment: 2013 May 01
Active, not recruiting
Phase 2
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Elias, A., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry Kapla...> ;Clinical Cancer Research. 2024 Feb 16
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
1 citations
Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.
Ciao-Sin Chen, Gary Zirpoli, William E Barlow, G Thomas Budd, Bryan McKiver, Lajos Pusztai, Gabriel N Hortobagyi, Kathy S Albain, M Imad Damaj, Andrew K Godwin, Alasta...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221.
Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, William E Barlow, Lajos Pusztai, Gabriel N Hortobagyi, Kathy S Albain, Andrew K Godwin, Alastair Thompson, N Lynn Henry, Ch...> ;Research Square. 2023 Sep 1
Effects ofandgenotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.
Delaney V Rutherford, Sarah Medley, Nicholas C Henderson, Christina L Gersch, Ted A Vandenberg, Kathy S Albain, Shaker R Dakhil, Nagendra R Tirumali, Julie R Gralow, G...> ;Pharmacogenomics. 2023 Aug 1
10 citations
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L Hirst, Christina Yau, Denise M Wolf, Wen...> ;Cancer Cell. 2023 Jun 12
3 citations
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer.
Rikki A Cannioto, Kristopher M Attwood, Evan W Davis, Lucas A Mendicino, Alan Hutson, Gary R Zirpoli, Li Tang, Nisha M Nair, William Barlow, Dawn L Hershman, Joseph M ...> ;JAMA Network Open. 2023 May 1
35 citations
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Tolaney, S., Tarantino, P., Graham, N., Tayob, N., Parè, L., Villacampa, G., Dang, C., Yardley, D., Moy, B., Marcom, P., Albain, K., Rugo, H., Ellis, M., Shapira, I., ...> ;The Lancet. Oncology. 2023 Mar 1
2 citations
Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226).
Mattias Bergqvist, Adrian Nordmark, Amy Williams, Costanza Paoletti, William Barlow, Erin F Cobain, Rita S Mehta, Julie R Gralow, Gabriel N Hortobagyi, Kathy S Albain,...> ;Biomarkers. 2023 May 1
2 citations
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.
Corey W Speers, W Fraser Symmans, William E Barlow, Alex Trevarton, Stephanie The, Lili Du, James M Rae, Steven Shak, Rick Baehner, Priyanka Sharma, Lajos Pusztai, Gab...> ;Journal of Clinical Oncology. 2023 Apr 1
1 citations
Impact of Federal Lung Cancer Screening Policy on the Incidence of Early-stage Lung Cancer.
Matthew S Khouzam, Douglas E Wood, Wickii Vigneswaran, Amit Goyal, Cheryl Czerlanis, Shanda H Blackmon, Jessica Donington, Kathy S Albain, Richard K Freeman, Zaid M Ab...> ;The Annals of Thoracic Surgery. 2023 Apr 1
6 citations
Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Elias, A., Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S...> ;NPJ Breast Cancer. 2022 Dec 1
9 citations
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer tri...
M Marczyk, A Mrukwa, C Yau, D Wolf, Y-Y Chen, R Balassanian, R Nanda, B A Parker, G Krings, H Sattar, J C Zeck, K S Albain, J C Boughey, M C Liu, A D Elias, A S Clark,...> ;Annals of Oncology. 2022 Aug 1
74 citations
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials.
Joseph M Unger, Riha Vaidya, Kathy S Albain, Michael LeBlanc, Lori M Minasian, Carolyn C Gotay, N Lynn Henry, Michael J Fisch, Shing M Lee, Charles D Blanke, Dawn L He...> ;Journal of Clinical Oncology. 2022 May 1
8 citations
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TB...
Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A Yardley, Steven J Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani...> ;NPJ Breast Cancer. 2022 Feb 16
264 citations
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer
Kevin Kalinsky, William E. Barlow, Julie R. Gralow, Funda Meric-Bernstam, Kathy S. Albain, Daniel F. Hayes, Nan Lin, Edith A. Perez, Lori J. Goldstein, Stephen Chia, S...> ;The New England Journal of Medicine. 2021 Dec 1
34 citations
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Elias, A., Amy S. Clark, Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, Laura J. van't Veer, Douglas Yee, Stacy L. Moulder, Anne M. Wallace, A. Jo Chien, Claudin...> ;Nature Communications. 2021 Nov 5
12 citations
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kath...> ;NPJ Breast Cancer. 2021 Oct 5
37 citations
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Mi...> ;JAMA Oncology. 2021 Sep 16
7 citations
Evaluating Serum Thymidine Kinase 1 in Patients with Hormone Receptor-Positive Metastatic Breast Cancer Receiving First-line Endocrine Therapy in the SWOG S0226 Trial.
Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie Gralow, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka S...> ;Clinical Cancer Research. 2021 Sep 14
112 citations
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Rosie Bradley, Jeremy P Braybrooke, Richard Gray, Robert Kerrin Hills, Z Liu, Richard Peto, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn W. Taylor, S...> ;The Lancet. Oncology. 2021 Aug 1
117 citations
Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
Lajos Pusztai, Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace, Erica String-Reasor, Judy C. Boughey, A. Jo Chien, Anthony D. Elias, Heather Beckwi...> ;Cancer Cell. 2021 Jul 12
1 citations
Socioeconomic Disparities in Non-Small Cell Lung Cancer With Brain Metastases at Presentation: A Population-Based Study
Ignacio Jusué-Torres, Alicia Hulbert, Jehad Zakaria, Kathy S. Albain, Courtney Hentz, Edward Melian, Jigisha P. Thakkar, Vikram C. Prabhu> ;World Neurosurgery. 2021 Jul 10
14 citations
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Tr...
Kathryn J. Ruddy, Yue Zheng, Nabihah Tayob, Jiani Hu, Chau T. Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese M. Mulvey, Ron Bose,...> ;Breast Cancer Research and Treatment. 2021 Jun 12
64 citations
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
Sara M. Tolaney, Nabihah Tayob, Chau T. Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese M. Mulvey, Ron Bose, Jiani Hu, Douglas Wec...> ;Journal of Clinical Oncology. 2021 Jun 2
Join now to see all

Press Mentions

Loyola University Chicago’s Kathy Albain, MD to Receive Prestigious National Award for Pioneering Breast Cancer ResearchJune 3rd, 2022
Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019
The FDA’s Accelerated Drug Approval Program Is Failing to Protect Cancer PatientsJune 3rd, 2019
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Gottlieb Memorial HospitalMelrose Park, Illinois
Loyola University Medical CenterMaywood, Illinois